Evidence map›Paper›PMID 42387055›Full record

ArticleOncogene2026

Matrix stiffness drives HCC invasion and metastasis via interfering with TRIM21-mediated SCD1 ubiquitination.

Ye Xu, Jia-Jun Li, Lian-Er Zhou, Hua-Hua Liu, Jia-Mei Yao, Wen-Qiang Gao, Rui Zhang, Jie Chen, Jun Chen, Dong-Mei Gao and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ye Xu *Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Jia-Jun Li *Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.ORCID http://orcid.org/0009-0008-8760-1365
Lian-Er Zhou *Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Hua-Hua LiuLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Jia-Mei YaoLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Wen-Qiang GaoLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Rui ZhangLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Jie ChenLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Jun ChenLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Dong-Mei GaoLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Jie-Feng CuiLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Zheng-Gang RenLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Shao-Lai ZhouLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China. zhoushaolai99@sina.com.ORCID http://orcid.org/0000-0002-8526-5221
Rong-Xin ChenLiver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China. chen.rongxin@zs-hospital.sh.cn.ORCID http://orcid.org/0000-0001-8508-516X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix stiffness drives the invasion and metastasis of hepatocellular carcinoma (HCC), wherein stearoyl-CoA desaturase 1 (SCD1), as a bona fide functional downstream effector of matrix stiffness, mediates HCC cell invasion and metastasis. However, the regulatory mechanism of SCD1 in response to matrix stiffness remains elusive. In this study, we identified a novel mechanism whereby F-actin cytoskeletal stress fiber assembly, triggered by increased matrix stiffness, sequesters the SCD1-targeting E3 ubiquitin ligase tripartite motif-containing protein 21 (TRIM21), resulting in reduced proteasomal degradation of SCD1 and consequently increased SCD1 protein levels, leading to HCC cell invasion and metastasis. When HCC cells were plated on soft substrates, a significant downregulation of HCC cell invasion was observed, a condition under which F-actin stress fiber disassembly released the SCD1-targeting TRIM21, leading to accelerated SCD1 proteasomal degradation and decreased SCD1 protein levels. Mechanistically, TRIM21 catalyzes K48-linked ubiquitination of SCD1 at lysine 68 (K68), resulting in proteasome-dependent degradation of SCD1, a process modulated by matrix stiffness. Genetic overexpression of TRIM21 suppresses HCC invasion and metastasis in vivo. In human HCC samples, increased collagen I content (a surrogate marker of matrix stiffness) together with TRIM21/F-actin co-localization predicted poor survival in HCC patients. Our findings reveal a new mechanotransduction pathway involving F-actin cytoskeleton stress fiber (dis)assembly, TRIM21, and SCD1 that responds to matrix stiffness mechanical signals from the tumor microenvironment to drive HCC invasion and metastasis.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.